Focal Photocoagulation as an Adjunctive Therapy to Reduce the Burden of Intravitreal Injections in Macula Edema Patients, the LyoMAC2 Study.

AIM

To assess the efficacy of focal photocoagulation of capillary macroaneurysms (CMA) to reduce the burden of intravitreal injections (IVI) in patients with macular edema (ME).

MATERIALS AND METHODS

Retrospective multicenter study in patients with diabetic ME or ME secondary to retinal vein occlusion (ME-RVO). CMA associated with ME were selectively photocoagulated. Patients were followed for one year after photocoagulation.

RESULTS

93 eyes of 76 patients were included in this study. At 6 months after the laser (n = 93), there was a significant decrease in mean macular thickness (from 354 µm to 314 µm, < 0.001) and in mean IVI number (from 2.52 to 1.52 at 6 months, < 0.001). The mean BCVA remained stable (0.32 and 0.31 logMAR at baseline and 6 months, = 0.95). At 12 months (n = 81/93), there was a significant decrease in mean macular thickness (from 354 µm to 314 µm, < 0.001) and in mean IVI number (from 4.44 to 2.95 at 12 months, < 0.001), while the mean BCVA remained stable (0.32 and 0.30 logMAR at baseline and 12 months, = 0.16).

CONCLUSION

Focal laser photocoagulation of CMA seems to be effective and safe for reducing the burden of IVI in patients with ME. Their screening during the follow-up should be considered closely.